文章：

MRI-超声融合引导下前列腺活检技术——操作流程详解

MRI–Ultrasound Fused Approach for Prostate Biopsy—How It Is Performed

原文发布日期：7 April 2024

DOI: 10.3390/cancers16071424

类型: Article

开放获取: 是

英文摘要：

The use of MRI–ultrasound image fusion targeted biopsy of the prostate in the face of an elevated serum PSA is now recommended by multiple societies, and results in improved detection of clinically significant cancer and, potentially, decreased detection of indolent disease. This combines the excellent sensitivity of MRI for clinically significant prostate cancer and the real-time biopsy guidance and confirmation of ultrasound. Both transperineal and transrectal approaches can be implemented using cognitive fusion, mechanical fusion with an articulated arm and electromagnetic registration, or pure software registration. The performance has been shown comparable to in-bore MRI biopsy performance. However, a number of factors influence the performance of this technique, including the quality and interpretation of the MRI, the approach used for biopsy, and experience of the practitioner, with most studies showing comparable performance of MRI–ultrasound fusion to in-bore targeted biopsy. Future improvements including artificial intelligence promise to refine the performance of all approaches.

摘要翻译： 

面对血清PSA升高的情况，目前多个学术团体推荐采用磁共振-超声图像融合引导的前列腺靶向活检技术。该方法结合了磁共振对临床显著性前列腺癌的高灵敏度优势，以及超声实时引导活检与定位确认的能力，能够提高临床显著性癌症的检出率，并可能减少对惰性病变的检出。该技术可通过经会阴或经直肠途径实施，具体融合方式包括认知融合、带关节臂的机械融合与电磁定位融合，或纯软件配准融合。研究显示其检测性能与磁共振腔内靶向活检相当。然而，该技术的实施效果受多种因素影响，包括磁共振图像质量与判读水平、活检路径选择以及操作者经验，多数研究表明磁共振-超声融合活检与腔内靶向活检具有相当的诊断效能。未来包括人工智能在内的技术改进有望进一步提升各类方法的操作性能。

原文链接：

MRI–Ultrasound Fused Approach for Prostate Biopsy—How It Is Performed